Premium
EFFECT OF AZATHIOPRINE AND CARBON TETRACHLORIDE ON INDUCTION OF HYPERPLASTIC LIVER NODULE AND HEPATOCELLULAR CARCINOMA BY DIETHYLNITROSAMINE AND N‐ 2‐FLUORENYLACETAMIDE IN RATS
Author(s) -
Sakata Tatsuro,
Watanabe Akiharu,
Takei Nobuyuki,
Shiota Tetsuya,
Nakatsukasa Harushige,
Fujiwara Masachika,
Kobayashi Michio,
Nagashima Hideo
Publication year - 1983
Publication title -
annals of the new york academy of sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.712
H-Index - 248
eISSN - 1749-6632
pISSN - 0077-8923
DOI - 10.1111/j.1749-6632.1983.tb32872.x
Subject(s) - carbon tetrachloride , ccl4 , hepatocellular carcinoma , medicine , chemistry , azathioprine , endocrinology , organic chemistry , disease
The enhancing or inhibitory action of the hepatotoxic agents, carbon tetrachloride (CCl4) and azathioprine (AZP), on the evolution of hyperplastic liver nodule (HN) and hepatocellular carcinoma (HCC) in diethylnitrosamine (DEN)- and N-2-fluorenylacetamide (FAA)-treated rats (control group) was tested. The area of gamma-glutamyl transpeptidase(gamma-GTP)-positive HN and/or foci in the eighth week was remarkably small in rats fed on a diet containing FAA and AZP (the AZP group), but was quite large in rats fed a diet containing FAA in addition to repeated CCl4 injections (the CCl4 group). HCC was first detected in the 21st week and the incidence of HCC within the 36 weeks of the experiment was very high in the CCl4 group. However, no tumor, including HCC, was detected in the AZP group during this observation period. No essential differences in the biochemical characteristics of HCC between the control group and the CCl4 group were observed with respect to several enzyme activities. The increased activity of liver aniline hydroxylase observed 12 hr after the administration of FAA, AZP, or DEN decreased when AZP was administered simultaneously with FAA to rats treated with DEN in advance. The mechanisms of the enhancing of inhibitory effect observed are discussed with special reference to the drug-drug interactions.